Align Technology, Inc.
ALGN
NASDAQ·Healthcare·Medical - Devices·Mkt cap $11.4B
$158.64
▼ -0.76%
P/E
27.59
Mkt Cap
$11.4B
52-Wk Range
$122.00–$200.44
52-Week Range
$122.00 - $200.44
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 15.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- First-mover advantage in clear aligner technology
- Proprietary 3D scanning and design software
- Strong brand recognition in dental professionals market
- Comprehensive digital treatment ecosystem
Bear Case
1 risk
- Above-average volatility (beta 1.6).
Growth
Stable outlook
Global orthodontic market expansion
Value
Attractively priced below Medical Devices peer average
Momentum
Weak
-7.8% over 3m
Quality
Excellent
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying ALGN right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 28, 2026
JUL 29, 2026
Reported EPS of $2.64 vs $2.62 consensus (+0.8% surprise). Revenue of $1.1B vs $1.1B expected (+0.4%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+0.8%
Revenue trend · last 8Q
—
+4%
-2%
-2%
+2%
+5%
+6%
+4%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$977.9M
$995.2M
$979.3M
$1.0B
$995.7M
$1.0B
$1.0B
$1.1B
Margins · last 8Q
Gross
71.7%
Operating
11.7%
Profit
10.3%
Wall Street consensus
7 analysts · 57% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
57%
Hold
43%
Sell
0%
Median Price Target
—
Latest: Needham · Jul 30, 2026
vs Industry
How ALGN stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related